Investment in Joint Ventures (Details Textual) (USD $) Share data in Millions, except Per Share data, unless otherwise specified	3 Months Ended		12 Months Ended	3 Months Ended					3 Months Ended		3 Months Ended
	Mar. 31, 2014 Products	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014 Medical Joint Venture Instruments	Dec. 31, 2013 Medical Joint Venture	Jul. 01, 2013 Medical Joint Venture	Mar. 31, 2013 Medical Joint Venture	Mar. 31, 2011 Medical Joint Venture	Mar. 31, 2014 Education Joint Venture	Mar. 31, 2013 Education Joint Venture	Mar. 31, 2014 Parent Company
Investment in Medical Joint Venture (Textual) [Abstract]
Joint venture owned by the entity	50.00%					45.50%		50.00%		50.00%
Contribution of Milestone in joint venture				$ 1,500,000							$ 245,000
Capital contribution				1,500,000
Instrument inception period				30 months
Contingency associated with the return of capital to Beijing 3H							0
Number of development of products for medical joint venture	2
Number of development of instruments				2
Loss from Medical Joint Venture	(130,523)
Sale of stock, number of shares					2
Sale of stock, price per share					$ 1.50
Sale of stock, value					3,000,000
Net proceeds received in joint venture					2,363,000
Percentage of ownership before transaction					50.00%
Percentage of ownership after transaction					45.50%
Gain on dilution effect					1,363,650
Legal fees related to the FDA (510k) certifications			39,153
Investment in Milestone Medical Inc	852,295		924,115
Total expenses incurred on joint venture				287,000
Reimbursable expense included in account receivable, net				48,641
Other charges	134,414	17,015		24,553
Loan from parent company CEO		50,000
Loss on joint venture									$ 6,830